Corpus Intelligence IC Memo — COMMUNITY HOSPITAL INC. 2026-04-26 09:06 UTC
IC Memo — COMMUNITY HOSPITAL INC.
Investment Committee Memorandum | AL | 37 beds | Grade C | EBITDA uplift $1.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

COMMUNITY HOSPITAL INC.

CCN 010034 | ELMORE, AL | 37 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

COMMUNITY HOSPITAL INC. is a 37-bed under-performing / distressed in ELMORE, AL with $14.6M in net patient revenue and a -34.0% operating margin. The hospital serves a payer mix of 27.2% Medicare, 7.5% Medicaid, and 65.4% commercial.

Thesis: Turnaround. Our ML models identify $1.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -34.0% to -26.6% (+736bps).

Net Revenue HCRIS$14.6M
Current EBITDA COMPUTED$-5.0M
Operating Margin COMPUTED-34.0%
Occupancy HCRIS14.6%
Revenue / Bed COMPUTED$396K
Net-to-Gross HCRIS50.9%
Distress Probability ML60.3%

2. Market Context & Competitive Position

115
AL Hospitals
-8.5%
State Median Margin
57
Comparable Hospitals

AL has 115 Medicare-certified hospitals with a median operating margin of -8.5%. The target's margin of -34.0% places it below the state median. Among 57 size-comparable peers (18-74 beds), the median margin is -16.2%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (18-74), prioritizing same-state peers. 57 hospitals in the comp set.

HospitalStateBedsRevenueMargin
COMMUNITY HOSPITAL INC. (Target)AL37$14.6M-34.0%
ATHENS LIMESTONEAL66$88.9M-20.9%
RUSSELL MEDICAL CENTERAL45$75.3M-14.8%
JACK HUGHSTON MEMORIAL HOSPITAAL47$75.2M6.5%
EASTPOINTE HOSPITALAL66$56.6M-50.0%
NORTH BALDWIN INFIRMARYAL35$55.3M-3.3%
PRATTVILLE BAPTIST HOSPITALAL55$53.5M-16.2%
HIGHLANDS MEDICAL CENTERAL45$45.9M-30.2%
ST. VINCENTS ST. CLAIRAL40$40.8M8.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$307K+210bp18mo
Cost to Collect4.5%2.5%$293K+200bp12mo
Denial Rate Reduction12.0%6.5%$290K+198bp12mo
A/R Days Reduction5200.0%3800.0%$178K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+7bp6mo

5. EBITDA Bridge

Net Collection Rate
$307K
Cost to Collect
$293K
Denial Rate Reduction
$290K
A/R Days Reduction
$178K
Clean Claim Rate
$10K
Total EBITDA Uplift$1.1M
Current EBITDA$-5.0M
+ RCM Uplift+$1.1M
Pro Forma EBITDA$-3.9M
Current Margin-34.0%
Pro Forma Margin-26.6%
WC Released (1x)$562K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-7.7M$-22.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-7.7M$-26.7M0.00x-100.0%
Bull Case9.0x11.0x$-6.9M$-25.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-6.9M$-30.0M0.00x-100.0%
Bear Case11.0x10.0x$-8.4M$-24.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-8.4M$-30.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 14.6%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 60.3% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 57 hospitals with 18-74 beds
  • Same-state prioritization (n=58)
  • Comp margins: P25=-28.7% / P50=-16.2% / P75=-2.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.